Prothena

This is a Multiple Ascending Dose Study to Evaluate the safety and tolerability of a drug called PRX012 in Subjects with Alzheimer’s Disease when compared to a placebo. Joining our clinical trial is a valuable opportunity to contribute to the advancement of medical research while receiving compensation for your participation. Additionally, we may offer reimbursements for clinical trial-related travel expenses and do not require health insurance. Don’t miss out on the chance to make a meaningful impact on the future of healthcare.

To be eligible for this study, a potential participant must:

Be between the ages of 55 and 85
Have a confirmed or suspected diagnosis of mild Alzheimer’s disease or mild cognitive impairment due to Alzheimer’s disease
Have noticed gradual and progressive change in memory function for at least 6 months
Be willing and able to complete brain imaging (MRI and PET scans)

"*" indicates required fields

Step 1 of 3

Submit your interest to our team of specialists

Attention: Make sure to check that you fit the eligibility requirements.

First Name*

Last Name*

Email*

Phone Number*